Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takamitsu Inoue

Showing results (41-50 of 185) with videos related to

Pageof 19
Sort By:
The Journal of Urology|November 13, 2004
Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinomaJiangang Yu, Tomonori Habuchi, Norihiko Tsuchiya, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 12, 2008
[A case of ruptured intra-renal aneurysm caused by renal allograft biopsy]Takamitsu Inoue, Shigeru Satoh, Mitsuru Saito, et al.
European Journal of Cell Biology|May 10, 2014
Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasisMihoko Sutoh Yoneyama, Shingo Hatakeyama, Tomonori Habuchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 19, 2016
Influence of everolimus on the pharmacokinetics of tacrolimus in Japanese renal transplant patientsTakenori Niioka, Hideaki Kagaya, Mitsuru Saito, et al.
International Journal of Oncology|December 9, 2004
CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasiaNorihiko Tsuchiya, Lizhong Wang, Yohei Horikawa, et al.
International Journal of Cancer|December 15, 2010
Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibilityNaoko Kawata, Norihiko Tsuchiya, Yohei Horikawa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 4, 2008
[Combination therapy consisting of gemcitabine, docetaxel and carboplatin as a second-line chemotherapy for patients with MVAC-treated metastatic urothelial carcinoma]Takamitsu Inoue, Takashi Obara, Mitsuru Saito, et al.
Transplantation|October 18, 2012
Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantationTakenori Niioka, Shigeru Satoh, Hideaki Kagaya, et al.
International Journal of Clinical Oncology|April 20, 2007
Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomyYohei Horikawa, Teruaki Kumazawa, Shintaro Narita, et al.
European Journal of Clinical Pharmacology|January 7, 2009
CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipientsShigeru Satoh, Mitsuru Saito, Takamitsu Inoue, et al.
Pageof 19

Showing results (41-50 of 185) with videos related to

Sort By:
Pageof 19
The Journal of Urology|November 13, 2004
Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinomaJiangang Yu, Tomonori Habuchi, Norihiko Tsuchiya, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 12, 2008
[A case of ruptured intra-renal aneurysm caused by renal allograft biopsy]Takamitsu Inoue, Shigeru Satoh, Mitsuru Saito, et al.
European Journal of Cell Biology|May 10, 2014
Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasisMihoko Sutoh Yoneyama, Shingo Hatakeyama, Tomonori Habuchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 19, 2016
Influence of everolimus on the pharmacokinetics of tacrolimus in Japanese renal transplant patientsTakenori Niioka, Hideaki Kagaya, Mitsuru Saito, et al.
International Journal of Oncology|December 9, 2004
CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasiaNorihiko Tsuchiya, Lizhong Wang, Yohei Horikawa, et al.
International Journal of Cancer|December 15, 2010
Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibilityNaoko Kawata, Norihiko Tsuchiya, Yohei Horikawa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 4, 2008
[Combination therapy consisting of gemcitabine, docetaxel and carboplatin as a second-line chemotherapy for patients with MVAC-treated metastatic urothelial carcinoma]Takamitsu Inoue, Takashi Obara, Mitsuru Saito, et al.
Transplantation|October 18, 2012
Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantationTakenori Niioka, Shigeru Satoh, Hideaki Kagaya, et al.
International Journal of Clinical Oncology|April 20, 2007
Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomyYohei Horikawa, Teruaki Kumazawa, Shintaro Narita, et al.
European Journal of Clinical Pharmacology|January 7, 2009
CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipientsShigeru Satoh, Mitsuru Saito, Takamitsu Inoue, et al.
Pageof 19